ID

24378

Descripción

NCT00079911 Study ID 100181 Clinical Study ID HS2100181 Study Title: An International, Randomized, Double-Blind, Placebo-Controlled Study of Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons with CD4+ lymphocyte count <100 cells/mm3. Patient Level Data Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00079911 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Terminated Generic Name: valaciclovir Trade Name: ZELITREX,Valtrex,RAPIVIR,Novirus Study Indication: Genital Herpes; HIV infection

Palabras clave

Versiones (1)
  1. 30/7/17 30/7/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

30 de julio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons INVESTIGATIONAL PRODUCT DISCONTINUATION NCT00079911

Inglés

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons INVESTIGATIONAL PRODUCT DISCONTINUATION NCT00079911

1 formularios  
Study administration
Descripción

Study administration

Subject Identifier
Descripción

Subject Identifier

Tipo de datos

integer

Alias
UMLS CUI [1]
C2348585
INVESTIGATIONAL PRODUCT DISCONTINUATION
Descripción

INVESTIGATIONAL PRODUCT DISCONTINUATION

Was the investigational product stopped pennanently before the end of the scheduled treatment period?
Descripción

early discontinuation

Tipo de datos

text

Alias
UMLS CUI [1]
C4288399
If Yes, check the primary reason the investigational product was stopped:
Descripción

reason drug discontinuation

Tipo de datos

text

Alias
UMLS CUI [1,1]
C4288399
UMLS CUI [1,2]
C0392360
Volver a la parte superior de la página

Similar models

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons INVESTIGATIONAL PRODUCT DISCONTINUATION NCT00079911

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Study administration
Subject Identifier
Item
Subject Identifier
integer
C2348585 (UMLS CUI [1])
Item Group
INVESTIGATIONAL PRODUCT DISCONTINUATION
Item
Was the investigational product stopped pennanently before the end of the scheduled treatment period?
text
C4288399 (UMLS CUI [1])
early discontinuation
Code List
Was the investigational product stopped pennanently before the end of the scheduled treatment period?
CL Item
Yes (Y)
CL Item
No (N)
Item
If Yes, check the primary reason the investigational product was stopped:
text
C4288399 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
reason drug discontinuation
Code List
If Yes, check the primary reason the investigational product was stopped:
CL Item
Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event (1)
CL Item
pages as appropriate) (pages as appropriate))
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Other. specify (Z)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial